Table 4 Most cited neuroblastoma papers
Authorsa | Article | Journal | Year | Vol | Issue | Page | TC | TC per year |
|---|---|---|---|---|---|---|---|---|
Broder GM, Pritchard J, Berthold F, Hedborg F | Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. | J Clin Oncol | 1993 | 11 | 8 | 1466–77 | 1450 | 55.7 |
Kaghad M,Bonnet H, Yang A, Caput D | Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers | Cell | 1997 | 90 | 4 | 809–19 | 1403 | 63.7 |
Broder GM | Neuroblastoma: Biological insights into a clinical enigma | Nat Rec Cancer | 2003 | 3 | 3 | 203–16 | 1328 | 83.0 |
Matthay KK, Villablanca JG, Seeger RC, Reynolds | Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid | N Engl J Med | 1999 | 341 | 16 | 1165–73 | 1246 | 62.3 |
Maris JM, Hogarty MD, Bagatell R, Cohn SL | Neuroblastoma | Lancet | 2010 | 369 | 9579 | 2106–20 | 1153 | 96.1 |
Maris JM | Recent Advances in Neuroblastoma | N Engl J Med | 2010 | 362 | 23 | 2202–11 | 792 | 88.0 |
Yu AL, Gilman AL, Ozkaynak MF, Sondel PM | Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma | N Engl J Med | 2010 | 363 | 14 | 1324–34 | 707 | 78.5 |
Mosse YP, Laudenslager M, Longo L, Maris JM | Identification of ALK as a major familial neuroblastoma predisposition gene | Nature | 2008 | 455 | 7215 | 930–5 | 704 | 64.0 |
Shimada H, Chatten J, Newton WA, Misugi K | Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas | J Natl Cancer Inst | 1984 | 73 | 2 | 405–16 | 686 | 19.6 |
Pule M, Savoldo B, Myers GD, Brenner MK | Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma | Nat Med | 2008 | 14 | 11 | 1264–70 | 674 | 61.3 |